Nhr MK, Pedersen MH, Gille A, Egerod KL, Engelstoft MS, Husted AS et al
Addressing the unspoken: sexual dysfunction in men with systemic lupus erythematosus, a call to action for rheumatologists
While these trials were not specifically designed to assess joint pain, patients with obesity-related joint pain who achieve significant weight loss through GLP-1 therapy often report improved mobility, reduced need for analgesics, and enhanced ability to engage in physical activitycreating a positive cycle of further weight management and joint health
Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons
NICE estimates about 220,000 people out of 3.4m people with a BMI over 35 and at least one weight-related illness will be able to access the drugs by 2028